By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Almac Discovery 

Almac House
20 Seagoe Industrial Estate
Craigavon    BT63 5QD  United Kingdom
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Biotechnology






Company News
Almac Discovery Is Granted Orphan Drug Designation For ALM201 Programme In Ovarian Cancer 7/6/2017 10:43:35 AM
Almac Discovery And Debiopharm Announce A Licensing Agreement For The Development Of A Novel Wee-1 Inhibitor 6/20/2017 9:36:32 AM
Almac Discovery Announce Key Wee-1 Kinase Patent Approval 5/8/2017 10:07:22 AM
Almac Discovery Secures Patent Protection For Novel Allosteric Akt inhibitor (ALM301) 2/4/2016 9:41:57 AM
Almac Discovery Wrangles R&D Deal Worth $363.5 Million+ From Genentech (RHHBY) 6/15/2015 6:31:19 AM
Almac Discovery Initiates Phase 1 Study Of ALM201 For The Treatment Of Patients With Advanced Ovarian Cancer And Other Solid Tumours 3/2/2015 10:08:28 AM
Almac Discovery Announces Licensing of ALM201 to Shin Poong Pharmaceutical Co., Ltd. (019170.KS) for Development and Marketing in South Korea 4/29/2013 8:00:12 AM
Almac Discovery Announces Selection of Preclinical Development Candidate for Its Allosteric Akt Inhibitor Programme. 12/17/2012 9:37:27 AM
Almac Discovery Announces Selection of Preclinical Development Candidate for Its Allosteric Akt Inhibitor Program 12/17/2012 6:26:28 AM
Beactica and Almac Discovery Announce Their First Fragment-Based Drug Discovery Agreement 12/6/2011 11:15:38 AM
12
//-->